Navigation Links
Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
Date:10/8/2008

ntial treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors. For a further discussion of these risks, please refer to the section "Risk Management" in Genmab's Annual Report, which is available on http://www.genmab.com. Genmab does not undertake any obligation to update or revise forward looking statements in this press release nor to confirm such statements in relation to actual results, unless required by law.

Genmab(R); the Y-shaped Genmab logo(R); HuMax(R); HuMax-CD4(R); HuMax-CD20(R); HuMax-EGFr(TM); HuMax-IL8(
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Genmab Announces Upcoming Ofatumumab Studies
2. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
3. Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study
4. Genmab Reaches Milestone in Ofatumumab Collaboration
5. Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer
6. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
7. Genmab Announces Updates on Phase III Cancer Studies
8. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
9. Bionomics Achieves US$1 Million Milestone Payment from Genmab
10. DAHANCA Initiates Head and Neck Cancer Study With Genmabs HuMax-EGFr
11. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... CVS/pharmacy and MinuteClinic health care centers ... H1N1 vaccine in 20 states and Washington, D.C. ... receiving H1N1 vaccines continue, many states have lifted ... receive the shot while supplies last. In ... is available at MinuteClinic locations across the country ...
(Date:12/16/2009)... Dec. 16 MAQUET Cardiovascular LLC, ... announced that it has signed a three-year ... industry,s leading supply contracting company, for MAQUET,s ... The VASOVIEW products assist healthcare providers in ... arteries using only small incisions. This allows ...
(Date:12/16/2009)... Dec. 16 Naurex Inc., a new ... and other CNS disorders based on its novel ... has initiated a Phase I clinical trial of ... the first subjects in the study. GLYX-13, ... modulator of the NMDA receptor, is initially being ...
Breaking Medicine Technology:CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3DeSilva + Phillips Mediabankers names Jim Brennan to Head Healthcare IT M 26amp 3BA Practice 13745 1DeSilva + Phillips Mediabankers names Jim Brennan to Head Healthcare IT M 26amp 3BA Practice 13745 2DeSilva + Phillips Mediabankers names Jim Brennan to Head Healthcare IT M 26amp 3BA Practice 13745 3PAINWeek 2009 Welcomes Over 1 000 Attendees 55797 1PAINWeek 2009 Welcomes Over 1 000 Attendees 55797 2PAINWeek 2009 Welcomes Over 1 000 Attendees 55797 3New Injury Rate Statistics for High School Athletes Highlight Need for Increased Prevention Efforts 55792 1New Injury Rate Statistics for High School Athletes Highlight Need for Increased Prevention Efforts 55792 2New Injury Rate Statistics for High School Athletes Highlight Need for Increased Prevention Efforts 55792 3
... May 30 (ASX: PGL;,Nasdaq: PGLA) New ... will,be presented tomorrow at the American Association ... by Progen,s collaborators at the Johns,Hopkins University., ... that compounds in Progen,s,existing preclinical cancer epigenetics ...
... Epeius Biotechnologies,( http://www.epeiusbiotech.com ) announced today the results ... metastatic bone and soft tissue sarcoma (J,Clin Oncol ... so far only targeted,gene therapy vector that has ... this open label study, cohorts of 6 to ...
Other Medicine Technology:Presentation of Data on Progen's Cancer Epigenetic Targets Platform 2Presentation of Data on Progen's Cancer Epigenetic Targets Platform 3Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008) 2
(Date:12/17/2009)... Howell, CEO of Arrayit Diagnostics, Inc., a ... Board: ARYC), today formally commented on the ... OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood ... development - the rights to which have ... Arrayit Corporation. ,, Howell stated, "In response ...
(Date:12/17/2009)... Simple interface and communications functions were determining factors. StaffKnex, ... recently announced it was selected by Lifespace Communities to ... , ... Cleveland, ... ), developers of web-based nurse scheduling and employee communication ...
(Date:12/17/2009)... Analysis reports, activity measures and outcomes reporting to monitor the ... claim costs and positive return on investment over the course ... ... Jacksonville, FL (PRWEB) December 17, 2009 -- HealthScreen Disease ... based cost risk analysis along with personalized nurse care, announced ...
(Date:12/16/2009)... Health care sector revenue increased by ... from $1.66 trillion in 2007, according to new ... is classified under the North American Industry Classification ... ) ,, These figures come from the ... Assistance , a series of tables which provides ...
(Date:12/16/2009)... -- Every year in the United States, 160,000 cases ... of the disease, making it the second leading cause ... , As researchers and clinicians fervently look for causes ... of studies producing more and more promising results ... genetics at Case Western Reserve University School of Medicine ...
Breaking Medicine News(10 mins):Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 2Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 3Health News:Arrayit Diagnostics to Bring First Pre-Symptomatic Ovarian Cancer Blood Test to Multi-Billion Dollar Diagnostic Market in 2010 4Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 2Health News:Lifespace Communities Selects StaffKnex Software for Nurse Scheduling and Employee Communications 3Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 3Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 2Health News:New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' 3
... N.Y., March 6 The national Tourette,Syndrome Association, Inc. ... House of Representatives approving The Mental Health Parity,Act by ... Wellstone Mental Health,and Addiction Equity Act (H.R. 1424), the ... part of health insurance packages equal,to the coverage in ...
... are tougher on replaced joints, study finds , , THURSDAY, March ... knee replacement surgeries each year may want to put away ... new study shows. , Biking and treadmill walking appear to ... had a knee replaced with an artificial joint, researchers found, ...
... Nonprofits Receive the GlaxoSmithKline 11th Annual IMPACT ... (NYSE:,GSK), one of the world,s leading research-based ... of the GlaxoSmithKline,11th Annual IMPACT Awards. Nonprofits ... in unrestricted funding. They include the Center ...
... IRVING, Texas, March 6 An Arlington, Texas,based ... 66 defendants in a,federal fraud lawsuit filed Thursday in ... people involved in automobile accidents at,clinics in Texas, Ohio, ... suit in the U.S. District Court,for the Northern District ...
... all soaps are alike - Dial ... Complete(R) is different., SCOTTSDALE, Ariz., March 6 ... illness. As a,matter of fact, people wash their hands an average of ... or equipment. This raises the,question of whether all soaps work equally well ...
... 6 In testimony before a,joint session of the ... John Rowan both praised and damned Congress for actions,taken ... enacted, could make a,huge difference in the lives of ... for the significant increases in,appropriations for veterans health care ...
Other Medicine News:Health News:Tourette Syndrome Association Celebrates the House Passage of LONG-AWAITED Mental Health Parity Legislation 2Health News:Biking, Walking Best for New Knees 2Health News:Biking, Walking Best for New Knees 3Health News:GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding 2Health News:GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding 3Health News:Alleged Multi-Million Dollar Fraud Ring Target of Federal Lawsuit 2Health News:Alleged Multi-Million Dollar Fraud Ring Target of Federal Lawsuit 3Health News:Does Antibacterial Soap Work? At Least One Really Does. 2Health News:VVA Calls for $5 Billion More for Health Care and Better Outreach 2
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
... Long Reach Pipet Tips (P2 - P10) - ... DNA and protein binding. Non-reactive. Beveled and referenced. ... to 10 L. Produced & packaged completely by ... Sterile Racked packaged 96 tips/rack and 10 racks/cs. ...
... Binding, Graduated, Pipet Tips (P2 - P10) - ... DNA and protein binding. Non-reactive. Beveled and referenced. ... to 10 L. Produced & packaged completely by ... Sterile Racked packaged 96 tips/rack and 10 racks/cs. ...
... Packed conveniently in plastic-wrapped racks of 96 ... useno need to autoclave. Sterilized Diamond Tips ... sterilization and are delivered with a certificate ... Sterilized Diamond Tips are certified free of ...
Medicine Products: